Kimia Farma’s Right to Respond
Tuesday, May 26, 2020
With reference to the May 12-18, 2020 edition of the Tempo magazine’s cover story titled The Biozek Controversy, which was published on May 12, 2020.
arsip tempo : 171351282356.
WE herewith exercise our right to respond and correction:
1. The selection of the rapid test product was based on studies, covering various aspects like quality, business and complete documents.
2. The quality and complete documents aspect of the rapid test product can be examined from the following papers:
a. Product information in the form of a package insert brochure and product picture;
b. EC-Declaration of Conformity of Biozek BNCP
...
Subscribe to continue reading.
We craft news with stories.
For the benefits of subscribing to Digital Tempo, See More
